Ann Meulemans
Direktor/Vorstandsmitglied bei Fonds Voor Wetenschappelijk Onderzoek - Vlaanderen
Profil
Ann Meulemans is the founder of OCTIMET Oncology NV, which was founded in 2016.
Currently, she is the Director at Fonds Voor Wetenschappelijk Onderzoek - Vlaanderen since 2020.
In the past, she worked as Vice President at Movetis NV from 2007 to 2009.
Dr. Meulemans has a graduate and doctorate degree from the University of Antwerp.
Aktive Positionen von Ann Meulemans
| Unternehmen | Position | Beginn |
|---|---|---|
Fonds Voor Wetenschappelijk Onderzoek - Vlaanderen
 Fonds Voor Wetenschappelijk Onderzoek - Vlaanderen Miscellaneous Commercial ServicesCommercial Services Fonds Voor Wetenschappelijk Onderzoek - Vlaanderen operates as an organization for scientific research. The private company is based in Brussels, Belgium. | Direktor/Vorstandsmitglied | 15.05.2020 |
Ehemalige bekannte Positionen von Ann Meulemans
| Unternehmen | Position | Ende |
|---|---|---|
OCTIMET Oncology NV
 OCTIMET Oncology NV BiotechnologyHealth Technology OCTIMET Oncology NV develops MET kinase inhibitors for the treatment of cancer. The company was founded by Timothy Perera, Ann Louise Meulemans, Paolo Comoglio, and Philip Owen in 2016 and is headquartered in Beerse, the Netherlands. | Gründer | - |
Movetis NV
 Movetis NV Pharmaceuticals: GenericHealth Technology Movetis NV operates as a pharmaceutical company, that focuses on the discovery, development, and commercialization of drugs for the treatment of diseases in the gastrointestinal (GI) area. Its products address GI disorders, such as severe chronic constipation, ascites, and paediatric reflux, as well as severe forms of GI motility disorders, including refractory gastro-oesophageal reflux disease. The company was founded in November 2006 and is headquartered in Turnhout, Belgium. | Corporate Officer/Principal | - |
Ausbildung von Ann Meulemans
| University of Antwerp | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Movetis NV
Movetis NV Pharmaceuticals: GenericHealth Technology Movetis NV operates as a pharmaceutical company, that focuses on the discovery, development, and commercialization of drugs for the treatment of diseases in the gastrointestinal (GI) area. Its products address GI disorders, such as severe chronic constipation, ascites, and paediatric reflux, as well as severe forms of GI motility disorders, including refractory gastro-oesophageal reflux disease. The company was founded in November 2006 and is headquartered in Turnhout, Belgium. | Health Technology |
OCTIMET Oncology NV
OCTIMET Oncology NV BiotechnologyHealth Technology OCTIMET Oncology NV develops MET kinase inhibitors for the treatment of cancer. The company was founded by Timothy Perera, Ann Louise Meulemans, Paolo Comoglio, and Philip Owen in 2016 and is headquartered in Beerse, the Netherlands. | Health Technology |
Fonds Voor Wetenschappelijk Onderzoek - Vlaanderen
Fonds Voor Wetenschappelijk Onderzoek - Vlaanderen Miscellaneous Commercial ServicesCommercial Services Fonds Voor Wetenschappelijk Onderzoek - Vlaanderen operates as an organization for scientific research. The private company is based in Brussels, Belgium. | Commercial Services |
